Anti-inflammatory effects of theophylline: Modulation of cytokine production

Annals of Allergy, Asthma and Immunology

Volumn 77, Issue 1, 1996, Pages 34-38

  Mascali, James J ^a   Cvietusa, Peter ^b   Negri, Julie ^a   Borish, Larry ^a,b  

^a UNIVERSITY OF COLORADO   (United States)

^b NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 10; INTERLEUKIN 4; THEOPHYLLINE;

ADOLESCENT; ADULT; ARTICLE; ASTHMA; CLINICAL ARTICLE; DISEASE SEVERITY; DRUG EFFECT; DRUG EFFICACY; FEMALE; HUMAN; HUMAN CELL; IMMUNOMODULATION; MALE; PRIORITY JOURNAL;

EID: 0029833439     PISSN: 10811206     EISSN: None     Source Type: Journal    
DOI: 10.1016/s1081-1206(10)63476-x     Document Type: Article

References (37)

1. Persson CGA. Overview of effects of theophylline. J Allergy Clin Immunol 1986;78:780-7.
2. Expert Panel Report, Guidelines for the Diagnosis and Management of Asthma, National Institutes of Health, Bethesda, MD, 1991.
3. Cannon JG, Nerad JL, Poutsiaka DD, Dinarello CA. Measuring circulating cytokines. J Appl Physiol 1993;75: 1897-902.
4. Abrams JS, Roncarolo M-G, Yssel H, et al. Strategies of anti-cytokine monoclonal antibody development: immunoassay of IL-10 and IL-5 in clinical samples. Immunol Rev 1992;127: 5-24.
5. Pauwels R, Van Renterghem D, Van Der Straeten M, et al. The effect of theophylline and enprofylline on allergen-induced bronchoconstriction. J Allergy Clin Immunol 1985;76:583-90.
6. Mapp C, Boschetto P, Dal Vecchio L, et al. Protective effect of anti-asthma drugs on late asthmatic reactions and increased airway responsiveness induced by toluene diisocyanate in sensitized subjects. Am Rev Respir Dis 1987;136:1403-7.
7. Ward AJM, McKenniff M, Evans JM, et al. Theophylline - an immunomodulatory role in asthma? Am Rev Respir Dis 1983;147:518-23.
8. Hendeles L, Harman E, Huang D, et al. Theophylline attenuation of airway responses to allergen: comparison with cromolyn metered-dose inhaler. J Allergy Clin Immunol 1995;95:505-14.
9. Andersson P, Brange C, Sonmark B, et al. Anti-anaphylactic and anti-inflammatory effects of xanthine in the lung. In: Anderssons KE, Persson CGA, eds. Anti-asthma xanthines and adenosine. Amsterdam: Excerpta Medica 1985: 187-92.
10. Nielson CP, Crowley JJ, Cusack BJ, Vestal RE. Therapeutic concentrations of theophylline and enprofylline potentiate catecholamine effects and inhibit leukocyte activation. J Allergy Clin Immunol 1986;78:660-7.
11. Nielson CP, Crowley JJ, Morgan ME, Vestal RE. Polymorphonuclear leukocyte inhibition by therapeutic concen-trations of theophylline is mediated by cyclic-3′,5′-adenosine monophosphate. Am Rev Respir Dis 1988;137: 25-30.
12. O'Neill SJ, Sitar DS, Klass DJ, et al. The pulmonary disposition of theophylline and its influence on human alveolar macrophage bactericidal function. Am Rev Respir Dis 1986;134: 1225-8.
13. Nelson S, Summer WR, Jakab GJ. Aminophylline-induced suppression of pulmonary antibacterial defenses. Am Rev Respir Dis 1985;131:923-7.
14. Hamid Q, Azzawi M, Ying S, et al. Expression of mRNA for interleukin-5 in mucosal bronchial biopsies from asthma. J Clin Invest 1991;87:1541-6.
15. Azzawi M, Bradley B, Jeffrey PK, et al. Identification of activated T lymphocytes and eosinophils in bronchial biopsies in stable atopic asthma. Am Rev Respir Dis 1990;142:1407-13.
16. Walker C, Kaegi MK, Braun P, Burt K. Activated T cells and eosinophilia in bronchoalveolar lavages from subjects with asthma correlated with disease severity. J Allergy Clin Immunol 1991;88:935-42.
17. Fink G, Mittelman M, Shohat B, Spitzer SA. Theophylline-induced alterations in cellular immunity in asthmatic patients. Clin Allergy 1987;17: 313-6.
18. Sustiel A, Joseph BZ, Rocklin RE, Borish L. Asthmatic patients have activated neutrophils that exhibit diminished responsiveness to adenosine. Am Rev Respir Dis 1989;140:1556-61.
19. Joseph BZ, Sustiel AM, Borish L. Neutrophils from asthmatics exhibit diminished responsiveness to adenosine which is reversed by theophylline. Inflammation 1992;16:101-16.
20. Essayan DM, Lichtenstein LM. Phosphodiesterase inhibitors: yesterday, today, and tomorrow. Insights Allergy 1994;9:1-12.
21. C. Mol Cell Biol 1993;13:4793-805.
22. Zabel P, Wolter DT, Schonharting MM, et al. Oxpentifylline in endotoxaemia. Lancet 1989;2:1474-7.
23. Fenton MJ. Review: transcription and post transcription regulation of interleukin 1 gene expression. Int J Immunopharmacol 1992;14:401-11.
24. Borish L, Dishuck J, Cox L, et al. Sezary syndrome presenting with elevated serum IgE and hypereosinophilia: role of dysregulated cytokine production. J Allergy Clin Immunol 1993;92:123-31.
25. Tsicopoulos A, Hamid Q, Varney V, et al. Preferential mRNA expression of TH1-type cells (IFN-gamma+, IL-2+) in classical delayed-type (tuberculin) hypersensitivity (DTH) reactions in human skin [Abstract]. J Allergy Clin Immunol 1992;89:239.
26. Del Prete GF, DeCarli M, Mastromauro C, et al. Purified protein derivative of Mycobacteria tuberculosis and excretory-secretory antigen(s) of Toxocara canis expand in vitro human T cells with stable and opposite (Type 1 T helper or type 2 T helper) profile of cytokine production. J Clin Invest 1991;88:346-50.
27. + T cell clones and resting T cells: specific inhibition of IL-2 production and proliferation. J Immunol 1993;150:4754-65.
28. Del Prete G, DeCarli M, Almerigogna F, et al. Human IL-10 is produced by both type 1 helper (Th1) and Type 2 helper (Th2) T cell clones and inhibits their antigen-specific proliferation and cytokine production. J Immunol 1993; 150:353-60.
29. Hsu D-H, Moore KW, and Spits H. Differential effects of interleukin-4 and -10 on interleukin-2 induced interferon-γ synthesis and lymphokine-activated killer activity. Int Immunol 1992;4:563-9.
30. Fiorentine DF, Zlotnik A, Mosmann TR, et al. IL-10 inhibits cytokine production by activated macrophages. J Immunol 1991;147:3815-22.
31. Ralph P, Nakoinz I, Sampson-Johannes A, et al. IL-10, T lymphocyte inhibitor of human blood cell production of IL-1 and tumor necrosis factor. J Immunol 1992;148:808-14.
32. Malefyt R de W, Abrams J, Bennett B, et al. Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J Exp Med 1991;174:1209-20.
33. D'Andrea A, Aste-Amezaga M, Vaiante NM, et al. Interleukin 10 (IL-10) inhibits human lymphocyte interferon-γ production by suppressing natural killer cell stimulatory factor/IL-12 synthesis in accessory cells. J Exp Med 1993;178:1041-8.
34. Punnonen J, deWall Malefyt R, van Vlasselaer P, et al. IL-10 and viral IL-10 prevent IL-4-induced IgE synthesis by inhibiting the accessory cell function of monocytes. J Immunol 1993;151:1280-9.
35. Takanaski S, Nonaka R, Xing Z, et al. Interleukin 10 inhibits lipopolysaccharide-induced survival and cytokine production by human peripheral blood eosinophils. J Exp Med 1994;180: 711-5.
36. Enk AH, Angeloni VL, Udey MC, Katz SI. Inhibition of Langerhans cell antigen-presenting function by IL-10: a role for IL-10 in induction of tolerance. J Immunol 1993;151:2390-8.
37. Borish L, Aarons A, Rumbyrt JP, et al. Interleukin-10 regulation in normal and asthmatic subjects. J Allergy Clin Immunol. (in press).